We invite you to attend the opening event of our new office and show lab in the Netherlands. The event takes place on March 30 at the Leiden Bio Science Park.
Together, the two companies look back at eight years of joint success having provided bioprocess solutions to hundreds of customers worldwide.
Securecell AG and DataHow AG announce their partnership with the goal to accelerate bioprocess development through harmonized data integration, overarching process automation, and machine learning-based models.
Since April 1, 2019, Securecell AG's headquarters are located in the industrial area - Luberzen - in Urdorf near Zurich. At that time, the move was made to the 1800 m2 area on the 1st floor with around 30 employees.
Integra One represents the synthesis of Securecell 30 years know-how in the biotech industry and is the first and unique solution delivering to the bioprocess industry “process intensification”, integrating technological efficiency, unparalleled spatial economy, and process security.
We are proud to announce our partnership with 908 Devices for data driven decisions and real-time extraction. Check the article on business wire!
Securecell, ZHAW, and Innosuisse are collaborating to generate an intelligent and integrated bioprocessing lab (i2BPLab) where the applicability of Lucullus® and Numera® will be expanded on top of their features to precultures, media preparation, warehousing, and detailed monitoring of bioprocess physiology.
Securecell is happy to join forces with Roche CustomBiotech to address the need for fully integrated and automated setups for bioprocessing.
Securecell today announced that it has introduced Sephara, a high performance in-situ filtration membrane for applications in bioprocess sampling and perfusion processes for use in selected bioprocess laboratories.
Automated sampling with Numera® as a central hub along a continuous bioprocess, enabling advanced real-time monitoring and process wide-control.
This article introduces the Lucullus® installation at Teva and highlights the workflow improvements through centralized process and data management.
Continuous automated blood sampling including glucose measurement in an animal model
Continuous automated blood sampling based on an animal model
Vaccines are one of the most effective, cost-efficient, and sustainable ways of controlling infectious diseases and have had a significant impact on public health and longevity as well as intensive livestock production.
The demand for vaccines, cell and gene therapeutics, and generally biologic manufacturing has continuously increased over the past decade.
In the “microbial drugs” department at the Helmholtz Center for Infection Research (HZI) in Braunschweig Germany, a high-tech laboratory environment was built embracing the bioprocessing 4.0 cornerstones.
Bioprocessing 4.0, the biopharmaceutical version of Industry 4.0, is defined as the digital transformation and automation of biopharmaceutical processes with the aim to drive manufacturing ...
Bioprocess laboratories with multiple lab-scale bioreactors often execute cultivation experiments in parallel with varying process parameters for process development and optimization purposes.
Every biopharmaceutical process aims for real-time monitoring and control of critical process parameters to minimize process variability and at the same time ensure predefined product quality.
How integrating Lucullus with iCELLis Bioreactors has helped in the development and manufacturing of vaccines.
From gene to a product: Integrated strain- and process engineering at the Jülich Research Center.
In this webinar, we present our approach, in which Securecell AG's Lucullus®, a process information management system, is combined with the DataHowLab, an automated machine-learning-based modeling platform from DataHow AG.
Subscribe to the Securecell Newsletter and stay up to date with all the latest product news, events and announcements. Don't miss out on any upcoming releases and conferences.